(Q43593251)

25 November 2017

1 reference

title

Managing drug reactions to sulfonamides and other drugs in HIV infection: desensitization rather than rechallenge? (English)

1 reference

25 November 2017

1 reference

Koopmans PP

1

1 reference

PubMed ID

9972526

25 November 2017

Burger DM

series ordinal

2

1 reference

PubMed ID

9972526

25 November 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

International Journal of Clinical Pharmacy

25 November 2017

1 reference

25 November 2017

20

1 reference

25 November 2017

6

1 reference

25 November 2017

253-257

1 reference

Desensitization to trimethoprim/sulfamethoxazole in HIV-infected patients

25 November 2017

1 reference

12 December 2020

Management of adverse reactions to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients

1 reference

12 December 2020

Rapid oral desensitization to trimethoprim-sulfamethoxazole in infants and children

1 reference

12 December 2020

A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus

1 reference

12 December 2020

A Severe, Unusual Reaction to Trimethoprim-Sulfamethoxazole in Patients Infected with Human Immunodeficiency Virus

1 reference

12 December 2020

Clindamycin desensitization in a patient with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Sulphadiazine desensitization in patients with AIDS and cerebral toxoplasmosis

1 reference

12 December 2020

Efficacy and safety of rechallenge with low-dose trimethoprim-sulphamethoxazole in previously hypersensitive HIV-infected patients.

1 reference

12 December 2020

Trimethoprim-sulphamethoxazole rechallenge in 20 previously allergic HIV-infected patients after homeopathic

1 reference

12 December 2020

Cerebral toxoplasmosis in childhood and adult HIV infection treated with 1-4 hydroxynaphthoquinone and rapid desensitization with pyrimethamine

1 reference

12 December 2020

Pharmacokinetics of sulphametrole and its metabolite N4-acetylsulphametrole in man

1 reference

12 December 2020

Trimethoprim-Sulfamethoxazole Oral Desensitization in Hemophiliacs Infected With Human Immunodeficiency Virus With a History of Hypersensitivity Reactions

1 reference

12 December 2020

Cutaneous Drug Reactions in Human Immunodeficiency Virus Infection

1 reference

12 December 2020

Managing HIV. Part 3: Mechanisms of disease. 3.5 How HIV leads to hypersensitivity reactions.

1 reference

12 December 2020

Efficacy and safety of desensitization to trimethoprim-sulfamethoxazole in human immunodeficiency virus-infected patients

1 reference

12 December 2020

Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency Syndrome

1 reference

12 December 2020

Adverse reactions to dapsone in persons infected with human immunodeficiency virus

1 reference

12 December 2020

A life-threatening adverse reaction during trimethoprim-sulfamethoxazole desensitization in a previously hypersensitive patient infected with human immunodeficiency virus

1 reference

12 December 2020

A severe hypersensitive reaction to trimethoprim-sulfamethoxazole in a patient infected with human immunodeficiency virus

1 reference

12 December 2020

"Treating through" hypersensitivity to co-trimoxazole in AIDS patients

1 reference

12 December 2020

Management of adverse reactions to prophylactic trimethoprim-sulfamethoxazole in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Allergic manifestations of human immunodeficiency virus (HIV) infection

1 reference

12 December 2020

Management of drug allergy in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Hypersensitivity reactions during antiretroviral regimens with protease inhibitors

1 reference

12 December 2020

Lues maligna, or ulceronodular syphilis, in a man infected with human immunodeficiency virus: case report and review

1 reference

12 December 2020

Trimethoprim-sulphamethoxazole desensitization in HIV-infected patients: an open study

1 reference

12 December 2020

Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: allergic or toxic?

1 reference

12 December 2020

Two-day oral desensitization to trimethoprim-sulfamethoxazole in HIV-infected patients.

1 reference

12 December 2020

A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group

1 reference

12 December 2020

Successful oral acyclovir desensitization

1 reference

12 December 2020

Complications of co-trimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men

1 reference

12 December 2020

Cutaneous reactions to trimethoprim-sulphametrole in AIDS patients treated for Pneumocystis carinii pneumonia

1 reference

12 December 2020

Reaction after re-exposure to trimethoprim-sulfamethoxazole

1 reference

12 December 2020

Rapid oral desensitization to trimethoprim-sulfamethoxazole (TMP-SMZ): use in prophylaxis for Pneumocystis carinii pneumonia in patients with AIDS who were previously intolerant to TMP-SMZ.

1 reference

12 December 2020

"Treating through" hypersensitivity to cotrimoxazole in children with HIV infection

1 reference

12 December 2020

Desensitization to dapsone in HIV-positive patients

1 reference

12 December 2020

Efficacy and safety of desensitization with sulfamethoxazole and trimethoprim in 48 previously hypersensitive patients infected with human immunodeficiency virus

1 reference

12 December 2020

Cutaneous disease and drug reactions in HIV infection

1 reference

12 December 2020

Desensitization to sulfonamides in patients with HIV infection

1 reference

12 December 2020

Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective, noncrossover study

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1008617019897

1 reference

25 November 2017

1 reference

PubMed ID

9972526